PONTCHARTRAIN CANCER CENTER

What PONTCHARTRAIN CANCER CENTER does

Pontchartrain Cancer Center is an independent community oncology practice founded in 2005 by Dr. David Oubre, providing medical oncology and hematology services to cancer patients across three locations in Covington, Hammond, and Bogalusa, Louisiana. Its clinical service line spans chemotherapy, immunotherapy, targeted therapy, hormonal therapy, genetic counseling and hereditary cancer risk assessment, on-site clinical trials, and coordination of radiation therapy and surgical oncology. The practice maintains hospital affiliations with four regional facilities and reports clinical trial enrollment rates of approximately 15% of patients, materially above the national community oncology average of roughly 6%.

The underlying technology stack is limited and largely third-party: the practice operates the Flatiron Health branded patient portal for digital patient engagement and otherwise relies on standard electronic medical record workflows used in community oncology. There is no evidence of proprietary software, in-house data products, or AI/ML capabilities; clinical decision support is delivered through conventional physician training and the practice's clinical trial relationships rather than algorithmic tooling.

The business model is fee-for-service medical billing: the practice generates revenue by submitting claims under standard CPT codes for evaluation and management visits, infusion services, and drug administration, reimbursed by Medicare, Medicaid, and commercial payers. Ancillary revenue is derived from clinical trial participation and from in-office dispensing of oncology drugs under typical buy-and-bill economics. Patient acquisition is driven by physician referral networks, hospital affiliations, and community visibility, including the founder's Castle Connolly Top Doctor recognition held for ten consecutive years.

Name

PONTCHARTRAIN CANCER CENTER

Legal name

Pontchartrain Cancer Center

Website

https://pcclouisiana.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

Pontchartrain Cancer Center is an independent community oncology practice operating three clinics in Louisiana that delivers chemotherapy, immunotherapy, genetic counseling, and clinical trials to cancer patients referred through local hospitals and physicians.

Ownership category

akta.pro rank

Product category

Oncology and Hematology Healthcare Services

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Medical Oncology (HLAKAFAB)

akta.pro secondary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

Keywords

• Medical oncology services
• Hematology treatment
• Chemotherapy administration
• Clinical trials oncology
• Genetic cancer counseling

Headquarters

HQ city

Covington

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Medical Oncology Services: Billing for physician services, chemotherapy administration, immunotherapy, targeted therapy, and hormonal therapy delivered at clinic locations and affiliated hospitals. Revenue is generated through standard medical billing using CPT codes and is reimbursed by health insurance plans including Medicare and Medicaid.
2. Clinical Trial Participation: The practice participates in clinical trials and receives compensation for study-required medical care, potentially including medication provision and clinical monitoring. Study-required medical care at no cost to the patient is a benefit of trial participation.
3. Genetic Counseling and Testing: Genetic counseling and testing services covered by approximately 97% of insurance companies. Coordination and interpretation of genetic testing services billed to insurance.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Pontchartrain Cancer Center is an independent community oncology and hematology practice delivering diagnosis, treatment, and long-term management of cancer and blood disorders. The practice administers chemotherapy, immunotherapy, targeted therapy, hormonal therapy, and biological therapy on site across three Louisiana clinic locations, coordinates multi-modality care including radiation therapy and surgery referrals, and operates an active clinical trials research department offering Phase II-IV studies. Physician services are supported by hereditary cancer risk assessment, genetic counseling and testing, financial counseling, and insurance pre-authorization support.

Product overview

Pontchartrain Cancer Center is an independent cancer center offering comprehensive oncology and hematology services across multiple Louisiana locations (Covington, Hammond, Bogalusa). The center provides a unified care platform combining chemotherapy, genetic counseling and testing, clinical trials, radiation therapy, surgery, and various support services including nutrition guidance, patient advocacy, and mental health support through programs like SPARK. The Patient Portal, powered by Flatiron Health, serves as the digital access point for patients. Core treatment modalities include chemotherapy, targeted therapy, hormonal therapy, biological therapy, and multi-modality approaches. The Cancer Library provides extensive patient education across 20+ cancer types.

Differentiator

Problem solved

Functional benefit

Products and services

• Chemotherapy Services On-site chemotherapy administration for cancer patients, including pre-treatment education sessions of approximately 1.5 hours, combination drug therapy, and management of side effects such as nausea, hair loss, and fatigue. Treatment plans are tailored per disease and patient profile.
• Genetic Counseling and Testing Hereditary cancer risk assessment and genetic counseling for individuals at high risk based on personal or family history, utilizing mutation risk models and coordination of genetic testing for breast, ovarian, colorectal, endometrial, and melanoma hereditary syndromes. Covered by approximately 97% of insurance companies.
• Clinical Trials Program Phase II-IV clinical trials in oncology and hematology including studies for lung cancer, solid tumors, breast cancer, colorectal cancer, leukemia, lymphoma, and other malignancies. Uses a central IRB model with study start-up timelines of 4-6 weeks. Study-required medical care is provided at no cost to participants.
• Comprehensive Treatment Overview Multi-modality cancer treatment coordination including surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy, and biological therapy tailored to the patient's disease, age, medical history, and family history.
• Radiation Therapy Coordination Coordination of radiation therapy using high-energy beams to damage cancer cell DNA, including external radiation and internal radiation (brachytherapy) delivered through affiliated hospital partners.
• Cancer Surgery Coordination Coordination of surgical services for cancer diagnosis (biopsy), staging, and treatment including removal of cancer and adjacent tissue, delivered through affiliated hospital surgeons.
• First Visit and Intake Services Initial patient intake services including physician meetings, diagnostic tests, treatment planning, insurance and financial counseling, and coordination of care with specialists.
• Cancer Nutrition Services Nutrition guidance and resources for cancer patients including dietary recommendations, community food resources, menu samples, and links to external nutrition programs and dietitians.
• PCC Advocates (CPAN Chapter) Patient advocacy chapter bringing together cancer patients, survivors, caregivers, and professionals to preserve local quality affordable cancer care, including round table discussions, advocacy events, and legislative outreach.
• SPARK Program Identity and self-esteem building workshops for women impacted by cancer, either as patients or as loved ones who fought alongside family members, helping participants process traumatic illness and find renewed purpose.

Quantifiable outcome

• 15% of patients participate in clinical trials compared to 6% nationally
• +1 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature3 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Community Oncology Alliance (COA)coreGTM or Marketing PartnerPontchartrain Cancer Center is a member of the Community Oncology Alliance's Patient Advocacy Network (CPAN). PCC launched its local CPAN chapter on June 29th, bringing together cancer patients, survivors, caregivers, medical professionals, and community members to preserve local, quality, affordable cancer care. The chapter participates in advocacy events including round table discussions and visits to The Hill.
• You Night Sisterhood (SPARK Program)minorStrategic or Co-development PartnerSPARK is a program of the You Night Sisterhood offered through Pontchartrain Cancer Center. It provides strategic identity and self-esteem building workshops for women impacted by cancer, either as someone diagnosed or as a loved one who fought alongside a friend or family member. Workshops are designed to help participants process the pain of traumatic illness and find renewed purpose.
• Flatiron HealthcoreTechnology or IntegrationPontchartrain Cancer Center uses Flatiron Health's patient portal (carespaceportal.com) to provide patients with secure access to medical records, appointment scheduling, and care team communication. The patient portal link is prominently featured on the PCC website for patient engagement.
• Lakeview Regional Medical CentercoreStrategic or Co-development PartnerPCC physicians are on staff at Lakeview Regional Medical Center. When hospitalization is required for cancer-related complications or treatment side effects, PCC doctors oversee oncology and hematology care working closely with hospital physicians and other specialists.
• St. Tammany Parish HospitalcoreStrategic or Co-development PartnerPCC physicians are on staff at St. Tammany Parish Hospital. When hospitalization is required for cancer-related complications or treatment side effects, PCC doctors oversee oncology and hematology care working closely with hospital physicians and other specialists.
• Our Lady of the Angels BogalusacoreStrategic or Co-development PartnerPCC physicians are on staff at Our Lady of the Angels Bogalusa. When hospitalization is required for cancer-related complications or treatment side effects, PCC doctors oversee oncology and hematology care working closely with hospital physicians and other specialists.
• North Oaks Medical CentercoreStrategic or Co-development PartnerPCC physicians are on staff at North Oaks Medical Center. When hospitalization is required for cancer-related complications or treatment side effects, PCC doctors oversee oncology and hematology care working closely with hospital physicians and other specialists.
• St. Tammany Cancer FundminorOthersDr. David Oubre serves as a board member of the St. Tammany Cancer Fund, a charitable organization that provides scholarships to college students affected by cancer.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• OneOncology: Platform formed by leading independent community oncology practices (including Tennessee Oncology) that provides practice management, technology, and capital support to affiliated independent oncology groups. Directly relevant as a potential affiliation partner for PCC.
• Ochsner Health System: Large Louisiana-based health system operating multi-specialty oncology programs and hospital-based cancer services across the Gulf Coast. Competes with PCC for oncology patients in overlapping parishes and represents the dominant hospital-system alternative.
• The US Oncology Network (McKesson): Network of independent community oncology practices supported by McKesson with shared infrastructure, payer contracting, and clinical research programs. Comparable platform-level alternative for an independent practice like PCC seeking scale and research access.
• HCA Healthcare / Sarah Cannon Cancer Institute: Hospital-affiliated cancer program within HCA Healthcare providing oncology and hematology services across a national footprint. Represents the hospital-system alternative to community oncology and a key competitive and consolidation force for independents like PCC.

Direct peers

• Florida Cancer Specialists & Research Institute: One of the largest independent medical oncology practices in the U.S., with a strong emphasis on Phase I–IV clinical trials and multi-site community clinic delivery. Highly comparable to PCC in core services (medical oncology, hematology, clinical research) and independent practice model.
• Tennessee Oncology: Large independent community oncology practice operating across Tennessee with a multi-modality platform including chemotherapy, genetic counseling, and a leading clinical research program. Closely comparable business model to PCC as an independent, physician-led community oncology group.
• Maryland Oncology Hematology: Independent community oncology and hematology practice affiliated with The US Oncology Network, providing chemotherapy, immunotherapy, and clinical trials across Maryland. Comparable to PCC in service mix and community-based oncology positioning.
• Regional Cancer Care Associates: Independent community oncology practice group serving the Northeast U.S. with multi-location chemotherapy, hematology, and clinical trial offerings. Comparable to PCC in independent, multi-site community oncology delivery and referral-based GTM.
• Oncology Hematology Care (OHC): Independent community oncology practice serving the Greater Cincinnati area with medical oncology, hematology, and clinical research services. Comparable in independent practice structure, multi-location clinic model, and research participation.

Regional players

• Mary Bird Perkins Cancer Center: Regional community-based cancer care organization serving Louisiana and the Gulf Coast with medical oncology, radiation oncology, and clinical trials. Direct regional competitor to PCC in overlapping Louisiana parishes, with similar community oncology service mix.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/pontchartraincancercenter
• Xx.com/PCCLouisiana

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PONTCHARTRAIN CANCER CENTER